Best clinical practice: Guidelines for managing major depression in primary medical care

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 7, 1999, Pages 19-28

  Schulberg, Herbert C ^a,e   Katon, Wayne J ^b   Simon, Gregory E ^b,c   Rush, A John ^d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

CLINICAL PRACTICE; DEPRESSION; DRUG EFFICACY; HEALTH CARE POLICY; HEALTH SERVICE; MAINTENANCE THERAPY; MEDICAL CARE; MEDICAL RESEARCH; META ANALYSIS; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; TREATMENT PLANNING;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; DRUG ADMINISTRATION SCHEDULE; HEALTH CARE COSTS; HUMANS; PRACTICE GUIDELINES; PRIMARY HEALTH CARE; PSYCHOTHERAPY; QUALITY OF HEALTH CARE; RANDOMIZED CONTROLLED TRIALS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME; UNITED STATES; UNITED STATES AGENCY FOR HEALTHCARE RESEARCH AND QUALITY;

EID: 0032914256     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. American Psychiatric Association. Practice Guideline for Major Depressive Disorder in Adults. Am J Psychiatry 1993;150:S1-S26
2. Lebowitz B, Pearson J, Schneider L, et al. Diagnosis and treatment of depression in late life: consensus statement update. JAMA 1997;278: 1186-1190
3. Paykel E, Priest R. Recognition and management of depression in general practice. BMJ 1992;305:1198-1202
4. Clinical Practice Guideline Number 5: Depression in Primary Care, vol 2. Treatment of Major Depression. Rockville, Md: US Dept Health Human Services, Agency for Health Care Policy and Research; 1993. AHCPR publication 93-0551
5. Klinkman M, Schwenk T, Coyne J. Depression in primary care: more like asthma than appendicitis: the Michigan Depression Project. Can J Psychiatry 1997;42:966-973
6. Solomon D, Keller M, Leon A, et al. Recovery from major depression: a 10-year prospective follow-up across multiple episodes. Arch Gen Psychiatry 1997;54:1001-1006
7. Schulberg H, Katon W, Simon G, et al. Treating major depression in primary care practice: an update of the AHCPR Practice Guidelines. Arch Gen Psychiatry 1998;55:1121-1127
8. Pincus H, Tanielian T, Marcus S, et al. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialities. JAMA 1998;279:526-531
9. Stahl SM. Basic psychopharmacology of antidepressants, pt 1: antidepressants have seven distinct mechanisms of action. J Clin Psychiatry 1998;59 (suppl 4):5-14
10. Trivedi M, Smith H, Rush AJ. Efficacy of antidepressants in primary care: a meta-analysis. Prim Care Psychiatry. In press
11. Moon C, Vince M. Treatment of major depression in general practice. Br J Clin Pract 1996;50:240-244
12. Ravindran AV, Judge R, Hunter BN, et al A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. J Clin Psychiatry 1997;58:112-118
13. Schulberg H, Block M, Madonia M, et al. Treating major depression in primary care practice: eight-month clinical outcomes. Arch Gen Psychiatry 1996;53:913-919
14. Simon G, VonKorif M, Heiligenstein J, et al. Initial antidepressant selection in primary care: effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA 1996;275:1897-1902
15. Crismon ML, Trivedi M, Pigott TA, et al. The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on medication treatment of major depressive disorder. J Clin Psychiatry 1999;60:142-156
16. Donoghue J, Typee A, Wildgust H. Cross sectional database analysis of antidepressant prescribing in general practice in the United Kingdom, 1993-1995. BMJ 1996;313:861-862
17. MacDonald T, McMahan A, Reid G, et al. Antidepressant drug use in primary care: a record linkage study in Tayside, Scotland. BMJ 1996;313: 860-861
18. Katon W, VonKorff M, Lin E, et al. Adequacy and duration of antidepressant treatment in primary care. Med Care 1992;30:67-76
19. Simon GE, VonKorff M, Wagner EH, et al. Patterns of antidepressant use in community practice. Gen Hosp Psychiatry 1993;15:399-408
20. Montgomery S, Kasper S. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Int Clin Psychopharmacol 1995;9(suppl 4):33-40
21. Anderson I, Tomenson B. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ 1995;310:1433-1438
22. Song F, Freemantle N, Sheldon T, et al. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ 1993;306:683-687
23. Hotopf M, Hardy R, Lewis G. Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analyses and investigation of heterogeneity. Br J Psychiatry 1997;170:120-127
24. Fairman K, Teitelbaum F, Drevets W, et al. Course of antidepressant treatment with tricyclic versus selective serotonin reuptake inhibitor agents: a comparison in managed care and fee-for-service environments. Am J Managed Care 1997;3:453-465
25. Fairman K, Drevets W, Kreisman J, et al. Course of antidepressant treatment, drug type, and prescriber's specialty. Psychiatr Serv 1998;49: 1180-1186
26. McFarland B. Cost effectiveness considerations for managed care systems: treating depression in primary care. Am J Med 1994;97(suppl 6A): 47S-57S
27. Jonsson B, Bebbington P. What price depression: the cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatry 1994; 164:665-673
28. LePen C, Levy E, Ravily V, et al. The cost of treatment dropout in depression: a cost-benefit analysis of fluoxetine vs tricyclics. J Affect Disord 1994;31:1-18
29. Montgomery SA, Brown RE, Clark M. Economic analysis of treating depression with nefazodone vs imipramine. Br J Psychiatry 1996;168: 768-771
30. Revicki DA, Brown RE, Keller MB, et al. Cost-effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settings. J Clin Psychiatry 1997;58:47-58
31. Sclar D, Robison L, Skaer T, et al. Antidepressant pharmacotherapy: economic outcomes in a Health Maintenance Organization. Clin Ther 1994; 16:715-730
32. Forder J, Kavanagh S, Fenyo A. A comparison of the cost-effectiveness of sertraline versus tricyclic antidepressants in primary care. J Affect Disord 1996;38:97-111
33. Croghan T, Laird T, Engelhart L, et al. Effect of antidepressant therapy on health care utilization and costs in primary care. Psychiatr Serv 1997;48: 1420-1426
34. Quitkin F, McGrath P, Stewart J, et al. Chronological milestones to guide drug change. Arch Gen Psychiatry 1996;53:785-792
35. Nierenberg A, McLean N, Alpert J, et al. Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. Am J Psychiatry 1995;152: 1500-1503
36. Katz MM, Koslow SH, Frazer A. Onset of antidepressant activity: reexamining the structure of depression and multiple actions of drugs. Depress Anxiety 1996-1997;4:257-267
37. Thase ME, Rush AJ. Treatment-resistant depression. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press; 1995:1081-1097
38. Sussman N, Joffe RT. Augmentation of antidepressant medication [introduction]. J Clin Psychiatry 1998;59(suppl 5):3-4
39. Thase M, Howland R, Friedman E. Treating antidepressant nonresponders with augmentation strategies: an overview. J Clin Psychiatry 1998;59(suppl 5):5-12
40. Nelson J. Combined drug treatment strategies for major depression. Psychiatr Ann 1998;28:197-203
41. Lin EH, Katon WJ, VonKorff M, et al. Relapse of depression in primary care: rate and clinical predictors. Arch Fam Med 1998;7:443-449
42. Reimherr F, Amsterdam J, Quitkin, F, et al. Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment. Am J Psychiatry 1998;155:1247-1253
43. Kupfer D, Frank E, Perel J, et al. Five-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1992;49:769-773
44. Byrne SE, Rothschild AJ. Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments. J Clin Psychiatry 1998;59:279-288
45. Scott A, Freeman C. Edinburgh primary care depression study: treatment outcome, patient satisfaction, and cost after 16 weeks. BMJ 1992;304: 883-887
46. Mynors-Wallis L, Gath D, Lloyd-Thomas A, et al. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ 1995;310:441-445
47. Catalan J, Gath D, Anastasiades P, et al. Evaluation of a brief psychological treatment for emotional disorders in primary care. Psychol Med 1991;21: 1013-1018
48. Mynors-Wallis L. Problem solving treatment: evidence for effectiveness and feasibility in primary care. Int J Psychiatry Med 1996;26:249-262
49. Watkins J, Leber W, Imber S, et al. Temporal course of depression. J Consult Clin Psychol 1993;61:858-864
50. Balslev Jorgensen M, Dam H, Bolwig T. The efficacy of psychotherapy in non-bipolar depression: a review. Acta Psychiatr Scand 1998;98:1-13
51. Fava G, Rafanelli C, Grandi S, et al. Prevention of recurrent depression with cognitive-behavioral therapy: preliminary findings. Arch Gen Psychiatry 1998;55:816-820
52. Mynors-Wallis L, Gath D. Predictors of treatment outcome for major depression in primary care. Psychol Med 1997;27:731-736
53. Schulberg H, Pilkonis P, Houck P. The severity of major depression and choice of treatment in primary care practice. J Consult Clin Psychol 1993; 66:932-938
54. Elkin I, Gibbons R, Shea M, et al. Initial severity and differential treatment outcome in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol 1995;63:841-847
55. Blackburn I, Bishop S, Glen A, et al. The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. Br J Psychiatry 1981;139: 181-189
56. Kovacs M, Rush AJ, Beck A, et al. Depressed outpatients treated with cognitive therapy or pharmacotherapy: a one-year follow-up. Arch Gen Psychiatry 1981;38:33-39
57. Katon W, Robinson P, VonKorff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry 1996; 53:924-932
58. Thase M, Greenhouse J, Frank E, et al. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry 1997;54:1009-1015
59. Eisenberg D, Kessler R, Foster C, et al. Unconventional medicine in the United States. New Engl J Med 1993;328:246-252
60. Ernst E, Rand J, Stevinson C. Complementary therapies for depression: an overview. Arch Gen Psychiatry 1998;55:1026-1032
61. Hylan T, Buesching D, Tollefson G. Health economic evaluations of antidepressants: a review. Depress Anxiety 1998;7:53-64
62. VonKorff M, Katon W, Lin E, et al. Evaluation of cost and cost offset of collaborative management of depressed patients in primary care. Psychosomatics 1998;60:143-149
63. Lave J, Frank R, Schulberg H, et al. Cost effectiveness of treatments for depression for primary care patients. Arch Gen Psychiatry 1998;55:645-651
64. Sturm R, Wells K. How can care for depression become more cost-effective? JAMA 1995;273:51-58
65. Thompson D, Hylan T, McMullen W, et al. Predictors of a medical-offset effect among patients receiving antidepressant therapy. Am J Psychiatry 1998;155:824-827
66. Rost K, Zhang M, Fortney J, et al. Expenditures for the treatment of major depression. Am J Psychiatry 1998;155:883-888
67. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA 1995; 273:1026-1031
68. Katon W, VonKorff M, Lin E, et al. Population-based care of depression: effective disease management strategies to decrease prevalence. Gen Hosp Psychiatry 1997;19:169-178
69. Katzelnick DJ, Simon GE, Pearson SD, et al. Randomized trial of a depression management program in high utilizers of medical care. In: New Research Program and Abstracts of the 151st Annual Meeting of the American Psychiatric Association; June 2, 1998; Toronto, Ontario, Canada. NR205:122
70. Rush A, Clayton P, Galle B, et al. Consensus Conference: Length of Antidepressant Therapy. Little Falls, NJ: Health Learning Systems; 1996